Impact of genome editing techniques

Impact of genome editing techniques

Breakthrough innovations across agriculture and human therapeutics

RELEASE DATE
30-Dec-2015
REGION
Global
Research Code: D6BE-01-00-00-00
SKU: FA00055-GL-MR_00322
$4,950.00
In stock
SKU
FA00055-GL-MR_00322
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Improvements and new gene editing techniques are constantly that have a high disruptive and revolutionary impact within the application for healthcare and other verticals. Accurate and highly precise manners of manipulating genetic content has not been present until the recent developments across the space of gene editing techniques. These tools, that have been developed can effectively provide researchers with the capacity to understand disease and potentially cure it. It also has the potential to impact the production rate and quality of agricultural and livestock products.

Recent developments across genome editing technologies have resulted in the creation of next generation nucleases, that have higher levels of accuracy when correcting genetic mutations and defects. The classes under the genome editing technologies are the 4 broad families of nucleases: ZFNs, TALENs, CRISPR/Cas9, and Meganucleases. Though there are non-nuclease-based approaches and various proprietary gene editing techniques, the industry favorites are still the nuclease-based approaches.

Gene editing technologies have an impact across multiple applications areas including plant and animal genetic engineering. However, the area of most disruption is across human cell line engineering, which enables the development of next generations therapies and drugs. However, the agricultural industry has seen more success with gene editing techniques largely due to the less stringent regulatory environment.

From a regional standpoint, the United States of America, has currently contributed the most toward the development of these unique and highly beneficial techniques. While Europe and Asia are closely following with increased investments entering these regions through partnership agreements.

Table of Contents

Research Scope

Where does gene editing stand today?

Segmentation–Application Overview

Segmentation–Technology overview

Main technology areas of focus enabling gene editing

Other technologies enabling gene editing

Technology capability

Technology capability : Comparative assessment

Approach : Technology Readiness Level (TRL)

TRL: ZFNs

TRL: TALENs

TRL: CRISPR/Cas9

Market Impact of Technology/Business Accelerators

Market Impact of Technology/Business Challenges

Innovation Ecosystem: Key Innovators

Agriculture–Plant-based applications

Player assessment across application

Breakthrough’s using gene editing technologies

Industrial bio-based applications

Player assessment across application

Breakthrough’s using gene editing technologies

Gene edited animal-based applications

Player assessment across application

Breakthrough’s using gene editing technologies

Human therapeutics applications

Player assessment across application

Utilization of Gene editing

Breakthrough’s using gene editing technologies

Breakthrough’s using gene editing technologies

Stakeholder Assessment

Stakeholder Assessment (continued)

Stakeholder Assessment (continued)

Stakeholder assessment

Stakeholder assessment (continued)

Stakeholder assessment (continued)

Partnership Assessment

Partnership Assessment

Partnership Assessment

Partnership Assessment

Approach–Company Profile

Editas Medicine

Intellia Therapeutics

CRISPR Therapeutics

Caribou

Regulatory Landscape

Geographic Assessment

Technology Roadmap

Patent search Scope

Patent Publishing Trends, Global, 2010–15*

Top 20 Patent holders, Global, 2010- 15*

Patents per Source Jurisdiction (Top 10 Patent offices), Global, 2010–15*

Key Contacts

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
Improvements and new gene editing techniques are constantly that have a high disruptive and revolutionary impact within the application for healthcare and other verticals. Accurate and highly precise manners of manipulating genetic content has not been present until the recent developments across the space of gene editing techniques. These tools, that have been developed can effectively provide researchers with the capacity to understand disease and potentially cure it. It also has the potential to impact the production rate and quality of agricultural and livestock products. Recent developments across genome editing technologies have resulted in the creation of next generation nucleases, that have higher levels of accuracy when correcting genetic mutations and defects. The classes under the genome editing technologies are the 4 broad families of nucleases: ZFNs, TALENs, CRISPR/Cas9, and Meganucleases. Though there are non-nuclease-based approaches and various proprietary gene editing techniques, the industry favorites are still the nuclease-based approaches. Gene editing technologies have an impact across multiple applications areas including plant and animal genetic engineering. However, the area of most disruption is across human cell line engineering, which enables the development of next generations therapies and drugs. However, the agricultural industry has seen more success with gene editing techniques largely due to the less stringent regulatory environment. From a regional standpoint, the United States of America, has currently contributed the most toward the development of these unique and highly beneficial techniques. While Europe and Asia are closely following with increased investments entering these regions through partnership agreements.
More Information
No Index No
Podcast No
Author Madhumitha Rangesa
Industries Agriculture and Nutrition
WIP Number D6BE-01-00-00-00
Keyword 1 Genome Editing Market
Keyword 2 Genome Editing Technology
Keyword 3 Genome Engineering
Is Prebook No